10x Genomics

TXG

Market cap $5.65B

TXG Hedge Fund Activity: Q1 2026 in Review

329 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in 10x Genomics (TXG) for Q1 2026, worth a combined $2.66B — up 32% from $2.02B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new TXG positions and 42 closed out — a net gain of 14 holders — while 115 added to existing stakes and 102 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $116M. The largest seller was Wellington Management Group, exiting entirely with an estimated $23.6M sold.

• 329 institutional investors held 10x Genomics (TXG) as of Q1 2026, up from 322 in Q4 2025.
• Funds reported $2.66B of 10x Genomics stock for Q1 2026, up 32% quarter-over-quarter.
• 56 funds opened new 10x Genomics positions in Q1 2026 and 42 closed out, a net change of +14 holders.
• The largest 10x Genomics buyer in Q1 2026 was Fidelity Investments, an estimated $116M added.
• The largest 10x Genomics seller in Q1 2026 was Wellington Management Group, an estimated $23.6M sold.

Based on aggregated 13F filings for Q1 2026.